UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacoepigenetics

Cacabelos, Ramón

1, 2019

Volltextzugriff (PDF)

Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease

Current medicinal chemistry, 2014, Vol.21 (19), p.2208-2217

2014

Volltextzugriff (PDF)

Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer’s Disease: A Review of Clinical Trials

TheScientificWorld, 2013-01, Vol.2013 (1), p.925702-925702

2013

Volltextzugriff (PDF)

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin

European journal of neurology, 2011-01, Vol.18 (1), p.59-68

2011

Volltextzugriff (PDF)

CFTR genotype-related body water and electrolyte balance during a marathon

Scandinavian journal of medicine & science in sports, 2016-09, Vol.26 (9), p.1036-1044

2016

Volltextzugriff (PDF)

Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)

Brain research, 2002-12, Vol.958 (1), p.210-221

2002

Volltextzugriff (PDF)

Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil

Current Alzheimer research, 2011-08, Vol.8 (5), p.583-591

2011

Volltextzugriff (PDF)

S06-04 Pharmacogenomics of Schizophrenia and Lipid Metabolism Alterations in CNS Disorders

Asian journal of psychiatry, 2011, Vol.4, p.S11-S11

Cacabelos, R

2011

Volltextzugriff (PDF)

Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals

Journal of neuroimmunology, 1999-06, Vol.97 (1), p.163-171

1999

Volltextzugriff (PDF)

A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

European journal of neurology, 2006-01, Vol.13 (1), p.43-54

2006

Volltextzugriff (PDF)

The Pathogenic Component of the APOE-TOMM40 Region in Alzheimer's disease: Its Implications in Metabolomics and Pharmacogenomics

Metabolomics, 2014-01, Vol.4 (1), p.1-1

Cacabelos, R

2014

Volltextzugriff (PDF)

Biochemistry, Cytogenetics and DMD Gene Mutations in South Indian Patients with Duchenne Muscular Dystrophy

International journal of human genetics, 2017-07, Vol.17 (3), p.126-134

2017

Volltextzugriff (PDF)

Alterations of serum TNF-alpha and IGF-I levels in vascular dementia

Journal of the neurological sciences, 2009, Vol.283 (1), p.282-282

2009

Volltextzugriff (PDF)

Pharmacogenomics and therapeutic prospects in Alzheimer's disease

Expert opinion on pharmacotherapy, 2005-10, Vol.6 (12), p.1967-1987

Cacabelos, Ramón

2005

Volltextzugriff (PDF)

Cytotoxicity effects induced by FR91 on human tumour cell lines

Proceedings of the Nutrition Society, 2010, Vol.69 (OCE3), Article E293

2010

Volltextzugriff (PDF)

Effects of FR91 on immune cells from healthy individuals and patients with non-Hodgkin lymphoma

Proceedings of the Nutrition Society, 2010, Vol.69 (OCE3), Article E292

2010

Volltextzugriff (PDF)

The application of functional genomics to Alzheimer's disease

Pharmacogenomics, 2003-09, Vol.4 (5), p.597-621

Cacabelos, Ramón

2003

Volltextzugriff (PDF)

Effects of FR-91 on immune cells from healthy individuals and from patients with non-Hodgkin lymphoma

BioMed research international, 2009-01, Vol.2009, p.187015-9

2009

Volltextzugriff (PDF)

Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease

Progress in neuro-psychopharmacology & biological psychiatry, 2001-10, Vol.25 (7), p.1341-1357

2001

Volltextzugriff (PDF)

A pharmacogenomic approach to Alzheimer's disease

Acta neurologica Scandinavica, 2000-01, Vol.102 (s176), p.12-19

2000

Volltextzugriff (PDF)

β-Amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield

Acta neuropathologica, 1998-05, Vol.95 (5), p.455-465

1998

Volltextzugriff (PDF)

Diagnosis of Alzheimer's disease: defining genetic profiles (genotype vs phenotype)

Acta neurologica Scandinavica, 1996-04, Vol.94 (S165), p.72-84

Cacabelos, R.

1996

Volltextzugriff (PDF)

Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia

Pharmacogenomics, 2004-12, Vol.5 (8), p.1049-1105

Cacabelos, Ramón

2004

Volltextzugriff (PDF)

Effects of fish-derived lipoprotein extracts on activation markers, Fas expression and apoptosis in peripheral blood lymphocytes

International immunopharmacology, 2005-02, Vol.5 (2), p.253-262

2005

Volltextzugriff (PDF)

Pharmacogenomics for the treatment of dementia

Annals of medicine (Helsinki), 2002, Vol.34 (5), p.357-379

Cacabelos, Ramón

2002

Volltextzugriff (PDF)

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(151)

Publikationsform

Artikel
(220)
Buchkapitel
(37)
Bücher
(1)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacoepigenetics

Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease

Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer’s Disease: A Review of Clinical Trials

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin

CFTR genotype-related body water and electrolyte balance during a marathon

Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)

Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil

S06-04 Pharmacogenomics of Schizophrenia and Lipid Metabolism Alterations in CNS Disorders

Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals

A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

The Pathogenic Component of the APOE-TOMM40 Region in Alzheimer's disease: Its Implications in Metabolomics and Pharmacogenomics

Biochemistry, Cytogenetics and DMD Gene Mutations in South Indian Patients with Duchenne Muscular Dystrophy

Alterations of serum TNF-alpha and IGF-I levels in vascular dementia

Pharmacogenomics and therapeutic prospects in Alzheimer's disease

Cytotoxicity effects induced by FR91 on human tumour cell lines

Effects of FR91 on immune cells from healthy individuals and patients with non-Hodgkin lymphoma

The application of functional genomics to Alzheimer's disease

Effects of FR-91 on immune cells from healthy individuals and from patients with non-Hodgkin lymphoma

Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease

A pharmacogenomic approach to Alzheimer's disease

β-Amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield

Diagnosis of Alzheimer's disease: defining genetic profiles (genotype vs phenotype)

Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia

Effects of fish-derived lipoprotein extracts on activation markers, Fas expression and apoptosis in peripheral blood lymphocytes

Pharmacogenomics for the treatment of dementia

Suchergebnisse filtern